Importance of 3-D image reconstruction of spectraldomain OCT on outcome of grid laser photocoagulation for diffuse diabetic macular edema

International Journal of Ophthalmology

Volumn 6, Issue 6, 2013, Pages 836-843

  Ophir, Avinoam ^a,b   Hanna, Rana ^a   Martinez, Michael R ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

3 D spectral domain optical coherence tomography; Epiretinal membrane; Evi membrane; Extrafoveal traction; Grid laser; Macular capillary dropout; Macular edema; Non center involved macular edema; Vitreofoveal traction

Indexed keywords

EID: 84894577382     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2013.06.17     Document Type: Article

References (27)

1. Early Treatment Diabetic Retinopathy Study Research Group Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report No. 19. Arch Ophthalmol. 1995;113(9):1144-1155.
2. Lee CM, Olk R J. Modified grid laser photocoagulation for diffuse diabetic macular edema: long term visual results. Ophthalmology. 1991;98(10):1594-1602.
3. Sobaci G, Ozge G, Erdurman C, Durukan HA, Bayraktar ZM. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema. Ophthalmologica. 2012;227(2):95-99.
4. Vemala R, Koshy S, Sivaprasad S. Qualitative and quantitative OCT response of diffuse diabetic macular edema to macular laser photocoagulation. Eye. 2011;25(7):901-908.
5. Elman MJ, Aiello LP, Beck RW, Bressler N M, Bressler SB, Edwards AR, Ferris FL, 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077.
6. Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM, Ozurdex CHAMPLAIN Study Group Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011;31(5):915-923.
7. Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Retina. 2012;32(2):314-321.
8. Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS, Da Vinci Study Group One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology. 2012;119(8):1658-1665.
9. Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol. 2005;139(4):638-652.
10. Karatas M, Ramirez JA, Ophir A. Diabetic vitreopapillary traction and macular edema. Eye (Lond) 2005;19(6):676-682.
11. Gupta P, Yee KM, Garcia P, Rosen RB, Parikh J, Hageman GS, Sadun AA, Sebag J. Vitreoschisis in macular diseases. Br J Ophthalmol. 2011;95(3):376-380.
12. Ophir A, Martinez RM. Epiretinal membranes and incomplete posterior vitreous detachment in diabetic macular edema, detected by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52(9):6414-6420.
13. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99(5):753-759.
14. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122(2):258-260.
15. Thomas D, Bunce C, Moorman C, Laidlaw AH. Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation and subretinal fluid in patients with diabetic macular edema. Retina. 2005;25(7):883-888.
16. Ophir A, Trevino A, Fatum S. Extrafoveal vitreous traction associated with diabetic diffuse macular edema. Eye (Lond) 2010;24(2):347-353.
17. Ophir A, Martinez MR, Mosqueda P, Trevino A. Vitreous traction and epiretinal membranes in diabetic macular edema using spectral-domain optical coherence tomography. Eye (Lond) 2010;24(10):1545-1553.
18. Catier A, Tadayoni R, Paques M, Erginay A, Haouchine B, Gaudric A, Massin P. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol. 2005;140(2):200-206.
19. Scott IU, Danis RP, Bressler SB, Bressler N M, Browning DJ, Qin H, Diabetic Retinopathy Clinical Research Network Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. Retina. 2009;29(5):613-617.
20. Koizumi H, Spaide RF, Fisher Y L, Freund KB, Klancnik JM, Jr, Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;145(3):509-517.
21. Domalpally A, Gangaputra S, Peng Q, Danis RP. Repeatability of retinal thickness measurements between spectraldomain and time-domain optical coherence tomography images in macular disease. Ophthalmic Surg Lasers Imaging. 2010;41 Suppl: S34-41.
22. Jyothi S, Sivaprasad S. Five-year visual outcome following laser photocoagulation of diabetic macular edema. Eye (Lond) 2011;25(7):851-858.
23. Chauhan DS, Marshall J. The interpretation of optical coherence tomography images of the retina. Invest Ophthalmol Vis Sci. 1999;40(10):2332- 2342.
24. Ritter M, Sacu S, Matt G, Dunavölgyi R, Bühl W, Prünte C, Schmidt-Erfurth U. Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study. Eye (Lond) 2011;25(10):1284-1293.
25. Bonini-Filho M, Costa RA, Calucci D, Jorge R, Melo LA, Jr, Scott IU. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study. Am J Ophthalmol. 2009;147(6):1022-1030.
26. Chung EJ, Roh MI, Kwon OW, Koh HJ. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina. 2008;28(7):957-963.
27. Yanoff M, Fine BS, Brucker A J, Eagle RC., Jr Pathology of human cystoid macular edema. Surv Ophthalmol. 1984;28 Suppl: 505-511.